BamSEC and AlphaSense Join Forces
Learn More

Neuraxis Inc. – Indentures

NYSE American: NRXS    
Share price (6/29/26): $7.14    
Market cap (6/29/26): $88.4 million

Indentures Filter

EX-4.1
from 10-K 1 page Description of the Registrant’s Securities
12/34/56
EX-4.1
from S-3 54 pages Neuraxis, Inc. and , Trustee Indenture Dated as of , 2024 Debt Securities Neuraxis, Inc. Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture, Dated as of ___, 2024
12/34/56
EX-4.1
from 10-K 1 page Description of the Registrant’s Securities
12/34/56
EX-4.23
from S-1/A 18 pages Appendix C Form of Warrant
12/34/56
EX-4.24
from S-1/A 16 pages Warrant Agency Agreement
12/34/56
EX-4.23
from S-1/A 16 pages Common Stock Purchase Warrant Neuraxis, INC
12/34/56
EX-4.8
from S-1/A 11 pages Indenture or similar
12/34/56
EX-4.21
from S-1 4 pages Second Amendment to Shareholders’ Agreement
12/34/56
EX-4.20
from S-1 22 pages Indenture or similar
12/34/56
EX-4.19
from S-1 16 pages Investor Rights Agreement
12/34/56
EX-4.18
from S-1 2 pages Indenture or similar
12/34/56
EX-4.17
from S-1 2 pages Side Letter
12/34/56
EX-4.16
from S-1 13 pages Masimo Corporation 52 Discovery Irvine, Ca 92618 Attention: Micah Young Its: Executive Vice President, Chief Financial Officer Re: Investment in Innovative Health Solutions, Inc. 1. Observation Rights
12/34/56
EX-4.15
from S-1 11 pages Indenture or similar
12/34/56
EX-4.14
from S-1 11 pages Indenture or similar
12/34/56
EX-4.13
from S-1 11 pages Common Share Purchase Warrant Neuraxis, INC
12/34/56
EX-4.12
from S-1 11 pages Indenture or similar
12/34/56
EX-4.11
from S-1 11 pages Indenture or similar
12/34/56
EX-4.10
from S-1 11 pages Indenture or similar
12/34/56
EX-4.9
from S-1 11 pages Common Share Purchase Warrant Neuraxis, INC
12/34/56